Juan Chipollini, MD
Dr. Chipollini attended the University of Arkansas for Medical Sciences where he graduated with honors. He completed general surgery internship and urology residency at the University Of Miami Miller School Of Medicine, and went on to specialize in genitourinary oncology at H. Lee Moffitt Cancer Center. He has an interest in enhanced recovery after oncologic surgery and ways to improve perioperative outcomes for cancer patients. He has presented at national conferences and has authored numerous book chapters and peer-reviewed publications. He is a member of the Society of Urologic Oncology and the Southwest Oncology Group. He enjoys running and cooking with his family and friends and is fluent in Spanish.
Urologic oncology, urothelial carcinoma, renal cell carcinoma, penile cancer, testicular cancer, prostate cancer
Chipollini, J., J. Garcia-Castaneda, A. Harb De la Rosa, S. Cheriyan, M. Azizi, and P. E. Spiess, "Important surgical concepts and techniques in inguinal lymph node dissection.", Curr Opin Urol, 2019 Feb 05. PMID: 30730389
Peyton, C. C., D. Tang, R. R. Reich, M. Azizi, J. Chipollini, J. M. Pow-Sang, B. Manley, P. E. Spiess, M. A. Poch, W. J. Sexton, et al., "Downstaging and Survival Outcomes Associated With Neoadjuvant Chemotherapy Regimens Among Patients Treated With Cystectomy for Muscle-Invasive Bladder Cancer.", JAMA Oncol, vol. 4, issue 11, pp. 1535-1542, 2018 Nov 01. PMCID: PMC6248089 PMID: 30178038
Peyton, C. C., J. Chipollini, M. Azizi, A. M. Kamat, S. M. Gilbert, and P. E. Spiess, "Updates on the use of intravesical therapies for non-muscle invasive bladder cancer: how, when and what.", World J Urol, 2018 Dec 07. PMID: 30535583
Chipollini, J., A. Necchi, and P. E. Spiess, "Outcomes for Patients with Node-positive Penile Cancer: Impact of Perioperative Systemic Therapies and the Importance of Surgical Intervention.", Eur Urol, vol. 74, issue 2, pp. 241-242, 2018 08. PMID: 29730019
Chipollini, J., M. Azizi, C. C. Peyton, D. H. Tang, J. Dhillon, and P. E. Spiess, "Implications of Programmed Death Ligand-1 Positivity in Non-Clear Cell Renal Cell Carcinoma.", J Kidney Cancer VHL, vol. 5, issue 4, pp. 6-13, 2018. PMCID: PMC6186848 PMID: 30386718